Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial
Research output: Contribution to journal › Journal article › Research › peer-review
Interferon beta is commonly used to treat patients with relapsing-remitting multiple sclerosis; however, the treatment is only partially effective in reducing relapses and progression of disability. Corticosteroids are used to treat relapses in patients with multiple sclerosis. We therefore aimed to investigate the combination of cyclic methylprednisolone and interferon beta for the treatment of relapsing-remitting multiple sclerosis.
| Original language | English |
|---|---|
| Journal | Lancet Neurology |
| Volume | 9 |
| Issue number | 7 |
| Pages (from-to) | 672-80 |
| Number of pages | 9 |
| ISSN | 1474-4422 |
| DOIs | |
| Publication status | Published - 1 Jul 2010 |
ID: 34093085